However, angiogenesis (hCD13-CD31+ ECs penetration) was observed in both groups, suggesting that the loss of ETV2 could block the generation of TDECs originating from the vasculogenesis of GBM but had little or no effect on tumor angiogenesis. This evidence concerns the gene ETV2 and glioblastoma.